Close this search box.


Martech company PFL receive investment from Goldman Sachs | B2B Marketing

Goldman Sachs has invested $25 million in marketing technology company PFL.

The investment will support research and development, product development and sales team growth for PFL’s Tactile Marketing Automation platform – an area of marketing the tech company deems pioneering.

The investment follows the rapid growth of PFL over the past three years which has seen revenue double in the last year.

Andrew Field, founder and CEO of PFL, said he hoped the investment from Goldman Sachs will further their innovations in the TMA field.

“Through this partnership, we have the opportunity to continue the innovation and growth of our TMA platform to create truly integrated, multichannel customer journeys,” said Field. “The investment from Goldman Sachs Growth Equity affirms their confidence in PFL’s leadership in the emerging tactile marketing category, and the growth opportunities for our company.”

Mark Middle, investor at Goldman Sachs, added: “PFL’s tactile marketing automation platform brings a unique set of capabilities to a market that has historically lacked automation, and its solutions deliver significant value and meaningful ROI to its customers.”

What is TMA?

Tactile marketing automation combines elements from CRM, marketing technology and direct mail. It is usually in the form of a software that can be integrated into existing marketing automation platforms. The TMA software will then create and send automated direct and dimensional mail triggered and based on your activity and output. 

Think Small: How to market to small businesses

In this marketing success pack, B2B Marketing and Earnest offer advice, opinion and first-hand experiences of targeting and engaging small businesses owners.

Learn how to target small business owners

Think Small: How to market to small businesses image

Related Articles

This website uses cookies to ensure you get the best experience on your website. Read more about cookies policy.